Back
ACVC Premium Access

Coronary angioplasty and COVID-19: are heparin requirements and thrombotic complications increasing?

Session: Live Abstract session - Antithrombotics and bleeding
Topic: Percutaneous Coronary Intervention (PCI)
Speaker: Miss H. Crane (London, GB)
Event: ACVC 2021

Congress Presentation

About the speaker

Miss Hannah Crane

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Trends in major bleeding events in patients with acute coronary syndrome.

Speaker: Doctor A. Cordero (Elche, ES)

Access
Abstract
Thumbnail

Long-term ischemic and bleeding risk with extended dual antiplatelet therapy after PCI in patients with 2018 ESC/EACTS myocardial revascularization guideline-endorsed high thrombotic risk features.

Speaker: Doctor H. Wang (Beijing, CN)

Access
Abstract
Thumbnail

Safety and efficacy of direct oral anticoagulants (DOACs) vs warfarin in patients with concurrent atrial fibrillation and bioprosthetic mitral or aortic valve replacement-a meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)

Access
Abstract
Thumbnail

Cardiovascular outcomes of clopidogrel and aspirin vs ticagrelor and aspirin in geriatric population with acute coronary syndrome-a systematic review and meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)

Access
Abstract
Thumbnail

Benefit and Harm of Extended Dual Antiplatelet Therapy After PCI in high-risk TWILIGHT-like patients with acute coronary syndrome

Speaker: Doctor H. Wang (Beijing, CN)

Access
Abstract
Thumbnail

Access the full session

Live Abstract session - Antithrombotics and bleeding

Speakers: Miss H. Crane, Doctor A. Cordero, Doctor H. Wang, Ms A. Abdul Razzack, Ms A. Abdul Razzack...
Access
Thumbnail

About the event

Image

ACVC 2021

13 March - 14 March 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb